Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

165.74
-0.8450-0.51%
Volume:5.47M
Turnover:909.34M
Market Cap:43.04B
PE:-11.66
High:167.08
Open:166.46
Low:165.59
Close:166.58
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:0.87
T/O Rate:2.11%
Dividend:2.53
Dividend Rate:1.53%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.25
PE(LYR):-11.66

Loading ...

Akari Therapeutics Selected to Showcase Novel PH1 ADC Payload Platform at Leading Global Oncology, ADC and Healthcare Forums

GlobeNewswire
·
Sep 08

Sector Update: Healthcare

MT Newswires Live
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

TIPRANKS
·
Sep 08

Concord Healthcare Controlling Shareholder Revises H-Share Pledge for Smaller Loan

TIPRANKS
·
Sep 08

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

GlobeNewswire
·
Sep 08

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Reuters
·
Sep 08

NovaBridge Biosciences Strengthens Board with Appointment of Veteran Healthcare Executive

TIPRANKS
·
Sep 08

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

GlobeNewswire
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Sep 08

Merck CEO Davis, R&D Head Li to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

Apitegromab’s Expanding FSHD Opportunity Supports Buy Rating; $65 Price Target Maintained

TIPRANKS
·
Sep 08

TEDA BIOMEDICAL Joins Forces with Xingchen Universal to Accelerate Embodied AI in Healthcare

Stock News
·
Sep 08

Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating

MT Newswires Live
·
Sep 08

Abbvie : Bofa Global Research Raises Price Objective to $282.00 from $276.00

THOMSON REUTERS
·
Sep 08

Merck & Co Inc : Guggenheim Raises Target Price to $170 from $146

THOMSON REUTERS
·
Sep 08

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

TIPRANKS
·
Sep 08

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 08

Health Care Roundup: Market Talk

Dow Jones
·
Sep 08

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Reuters
·
Sep 08